HB Wealth Management’s Akebia Therapeutics AKBA Stock Holding History

HB Wealth Management’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.2K	Buy	+16,881	New	+$20.1K	﹤0.01%	1702

Other funds holding AKBA

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

New York State Common Retirement Fund

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Parkwoods Wealth Partners Syracuse, New York $622M AUM 24.36% 1-Year Est. Return

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

HB Wealth Management's AKBA Position: Q2 2026 in Review

HB Wealth Management opened a new position in Akebia Therapeutics (AKBA) in Q2 2026: 16,881 shares worth $19.2K. The stake represents ﹤0.01% of the portfolio and ranks #1702 among its holdings.

36 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

HB Wealth Management held 16,881 shares of Akebia Therapeutics worth $19.2K as of Q2 2026.
Akebia Therapeutics was a new HB Wealth Management position in Q2 2026.
Akebia Therapeutics made up ﹤0.01% of HB Wealth Management's portfolio in Q2 2026, its #1702 holding.
36 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.